CLINICAL_TRIALS
trial_result
· 2024-06-04
Clinical Trial Update: Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.
Summary
A clinical trial update examining how endogenous insulin secretion declines in individuals diagnosed with Type 1 diabetes mellitus after age 30.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Diabetes Mellitus, Type 1, Progression | Status: COMPLETED